Social Determinants of Health and Continuous Glucose Monitoring Metrics in Type 1 or Type 2 Diabetes
-
By
-
Walter T. Williamson
-
Neo Kok
-
Joyce M. Lee
-
Jenna Wiens
-
Irina Gaynanova
-
July 1, 2026
-
Clinical Scorecard: Impact of Social Determinants on Continuous Glucose Monitoring Outcomes in Individuals with Type 1 and Type 2 Diabetes
At a Glance
| Category | Detail |
|---|
| Condition | Diabetes (Type 1 and Type 2) |
| Key Mechanisms | Influence of social determinants of health on glycemic outcomes and technology adoption. |
| Target Population | Adults and pediatric patients with Type 1 or Type 2 diabetes using continuous glucose monitoring. |
| Care Setting | Outpatient care at a single-center academic health system. |
Key Highlights
- Higher HbA1c levels are associated with lower rates of CGM adoption.
- Social determinants such as race and socioeconomic status significantly impact diabetes outcomes.
- CGM-derived metrics provide detailed insights into glycemic management beyond HbA1c.
Guideline-Based Recommendations
Diagnosis
- Confirm diabetes type via electronic health record review.
Management
- Utilize continuous glucose monitoring data to assess glycemic control.
Monitoring & Follow-up
- Evaluate CGM profiles for mean glucose, time in range, and glycemic variability.
Risks
- Consider the impact of social determinants on glycemic outcomes.
Patient & Prescribing Data
Patients with Type 1 or Type 2 diabetes receiving outpatient care.
CGM technology is associated with improved HbA1c outcomes across diverse populations.
Clinical Best Practices
- Incorporate social determinants of health into diabetes management strategies.
- Ensure adequate data availability for marginalized populations to improve glycemic management.
Related Resources & Content
